Expert Opinion on Verification of Antimicrobial Susceptibility Tests

On behalf of the Clinical and Laboratory Standards Institute (CLSI), the Expert Panel on Microbiology would like to respond to the recent commentary by Kirby and colleagues voicing concerns related to the verification of commercial antimicrobial susceptibility testing (AST) for new drugs that are introduced into the clinical laboratory (1). The CLSI Expert Panel on Microbiology oversees the direction and general guidance of the CLSI microbiology...